Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02121964 · ClinicalTrials.gov registry record · NA
Capsulectomy vs Capsulotomy With Repair in Direct Anterior Total Hip Arthroplasty
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
NCT02121964: Completed NA study, sponsored by Emory University.
NCT02121964 is a NA study that has completed, run by Emory University. The registered enrollment target is 98 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02121964, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
Study Summary
In this prospective, randomized study, investigators will look at the outcome of total hip arthroplasty through the anterior approach in regard to the surgical treatment of the anterior hip capsule. At this time, there are 2 different techniques: one is excising this capsule and the second one is cutting the capsule and repairing it at the end of the procedure. The investigators set out to determine whether incising or repairing the capsule will benefit the patients in terms of postoperative pain level, range of motion of the hip joint, joint stability, surgical time and blood loss. Both preserving and excising the joint capsule are accepted techniques in performing total hip arthroplasty. The Investigators hypothesize that capsulectomy may allow for reduction in operative time, provide superior surgical exposure, and increased range of motion after surgery. The influence on post operative pain and dislocation rate is unknown.
Primary Outcome
Measurement will be recorded taken with patient in the seated position with the hip flexed to 90 degrees. Strength will be measured when resistance is applied to the knee as the patient brings the leg up. The following scale will be used (each may be +/-, i.e. 5+): * 5 = NORMAL - the patient is able to actively move through the full available range of motion (ROM) against gravity and against maximal resistance * 4 = GOOD - the patient is able to actively move through the full available ROM agai
Interventions
- PROCEDURE Capsulectomy in Direct Anterior Total Hip Arthroplasty
- PROCEDURE Capsulotomy in Direct Anterior Total Hip Arthroplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2013-08 |
| Est. Completion | 2020-05-31 |
| Phase | NA |
What the finished NCT02121964 record still lists
NCT02121964 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Capsulectomy in Direct Anterior Total Hip Arthroplasty is the first listed.
NCT02121964 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02121964 about?
NCT02121964 is a clinical study titled "Capsulectomy vs Capsulotomy With Repair in Direct Anterior Total Hip Arthroplasty". In this prospective, randomized study, investigators will look at the outcome of total hip arthroplasty through the anterior approach in regard to the surgical treatment of the anterior hip capsule. At this time, there are 2 different techniques: one is excising this capsule and the second one is cu...
What is the current status of trial NCT02121964?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2013-08. Estimated completion is 2020-05-31.
What interventions are being tested in trial NCT02121964?
The interventions under investigation include: Capsulectomy in Direct Anterior Total Hip Arthroplasty (PROCEDURE), Capsulotomy in Direct Anterior Total Hip Arthroplasty (PROCEDURE).
Who is sponsoring clinical trial NCT02121964?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02121964's enrollment target sits among peer trials
98 922nd of 2000 higher than 1,078 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia